We used dexmedetomidine as a sedative drug during artificial ventilation for Gaucher disease myoclonic status epilepticus and experienced the termination of status myoclonus. The findings in this case suggest that dexmedetomidine may be effective for the treatment of status myoclonus.
Dexmedetomidine is an alpha-2 adrenoreceptor agonist that possesses sedative and analgesic properties and causes sympathetic inhibition. Dexmedetomidine has been investigated for a possible anticonvulsant effect and for use in epilepsy, but it is not clear whether dexmedetomidine has this anticonvulsant effect.
